Senior insider sale
President, Head of R&D at SYNDAX PHARMACEUTICALS INC — senior position signals high conviction
$89.7K
9.68K shares
What this filing means
GALLAGHER NEIL plans to sell 9.68K shares of SYNDAX PHARMACEUTICALS INC valued at approximately $89.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/10/2025ACC: 0001959173-25-004535
Officer· President, Head of R&D
Since Apr 2023
9.68K
Shares to sell
$89.7K
Approx. market value
9.68K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
6/30/2025
9.68KTotal acquired9.68K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/30/2025 | Restricted Stock Vesting Compensation | 9.68K | — |
| Total | 9.68K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
9.68K
Market value
$89.7K
7/10/2025
Total
Units
9.68K
Value
$89.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/10/2025 | 9.68K | $89.7K | NASDAQ | Planned |
| Total | 9.68K | $89.7K | ||